Teligent, Inc. Announces Second Quarter 2019 Results
BUENA, N.J., Aug. 05, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the second quarter ended June 30, 2019.
Second Quarter 2019 Highlights
Net revenues of $18.3 million for the second quarter of 2019, a $2.1 million increase over the same quarter in 2018 Gross margin of 47% for the second quarter of 2019, an 1,800 basis point increase from the 29% reported in the same q...